glp 1 and bone loss Effects of Glucagon-Like Peptide-1 receptor agonists on health in people living with obesity | Osteoporosis International GLP-1s and Bone Health: What

A glucagon-like peptide-1 (GLP-1) drug appears to slow cognitive decline by protecting the brain, according to Phase 2b clinical trial results reported at AAIC.

Safety Considerations and Managing Risks GI Side Effects: Transient issues like nausea, vomiting, and diarrhoea are common, especially during initial dose escalation

Learn more at the Dr

Discover the eligibility requirements and steps needed for this weight-loss prescription.

Women with uterine fibroids have a more than 80 percent higher risk of developing heart disease, according to a new study

Live Akkermansia A next-generation beneficial strain essential for gut health, supporting microbiome balance and gut lining integrity